La Finca Interacviva-Arachna Med is a licensed cultivator, producer, distributor, and seller of cannabis products in Colombia with export abilities into global markets
Chemesis International Inc. (OTC: CADMF) (CSE: CSI), is pleased to announce that it has entered into a binding Letter of Intent (“LOI”) to acquire 100% of Colombia-based La Finca Interacviva-Arachna Med SAS (“La Finca”), an integrated cannabis company that has been licensed and operational in Colombia since October, 2017.
La Finca has access to over 1000 acres of outdoor cultivation land and is aggressively exploring opportunities to expand. It is a founding member for the “Association for the Promotion of Hemp Growing,” a non-profit entity that is concentrated on providing education and promoting the expansion of cannabis plantations, while ensuring the growth of high-quality crops through technical advice. The company’s cultivation program is based on a decentralized model with partner farmers throughout the country, allowing small farmers to quickly generate high quality crops. Currently, La Finca has relationships with over 2,000 farming families across Colombia through various co-ops that comprise its land package.
La Finca also has a partnership with the largest university in Colombia, Universidad Nacional de Colombia, to develop seed strains that improve the yield of biomass and flower while shortening crop cycles. It has also partnered with Universidad Distrital Francisco José de Caldas, which focuses on the educational aspects of cannabis cultivation. The university provides distance education as well as in-class instruction to educate farmers on cannabis crops, ensuring they are able to produce high quality crops.
La Finca currently has several manufacturing relationships and CAD$2.5-million working capital available to expand its operations. The company has a manufacturing agreement for licensed cosmetic products under the La Finca brand. These products are licenced through the Instituto Nacional de Vigilancia de Medicamento (INVIMA) which is Colombia’s equivalent to the US Food and Drug Administration (US FDA). The company is heavily involved with INVIMA ensuring compliance with all regulations and health requirements.
Colombia is located close to the equator and boasts a 12-hour sun cycle that occurs year-round, allowing for harvesting to occur 365 days a year1. The mountainous geography of Colombia provides different thermal floors which allow for cultivation to occur in multiple climates, simultaneously. Colombia also has many free trade agreements that will allow for cost effective export of cannabis products around the world. The Company believes La Finca is particularly well positioned in a country that is quickly adapting cannabis regulations, thus providing an extremely lucrative investment opportunity for both short and long-term growth.
“Chemesis is continuing its expansion into the Latin American market, a region the Company believes is poised for international growth and expansion,” said Chemesis CEO, Edgar Montero. “With the acquisition of La Finca, the Company will acquire an asset in a country that is developing its cannabis industry for distribution around the world. We continue to execute our business plan that is focused on building long term growth in key markets around the world.”
The Company will acquire La Finca for $13,500,000 CAD in a combination of cash and common shares of the Company to be determined upon execution of the definitive agreement. All stock issued will be subject to a 36-month phased lock-up period. Closing of the transactions contemplated by the LOI are subject to regulatory approval.